The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded an indefinite delivery contract to Leidos, Inc. operating as Saic to provide comprehensive and rapid response services supporting research programs. With a potential value of $545,452,906 over seven years ending August 2028, the multiple award contract vehicle enables delivery orders for clinical trials, manufacturing, animal studies, analytics, storage, and basic research. Leidos was issued an initial $2 million one-year firm fixed price order for work in Bethesda, Maryland beginning September 2021.
The originating solicitation sought proposals for flexible domestic and international research capabilities across infectious, immunologic, and allergic diseases. Offerors were required to demonstrate expertise in clinical research, intramural research, vaccine development, clinical trials, chemistry manufacturing and controls, animal studies, bioinformatics, and regulatory services. Proposals had to support tasks coded to research organization and laboratory services North American Industry Classification System codes. The partial small business set aside and indefinite delivery/indefinite quantity structure aim to allow the National Institute of Allergy and Infectious Diseases to efficiently address evolving research requirements over seven years utilizing pre-competed contractors.
Generated 1/4/24, 10:05 PM